Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Guardant Health Inc (GH)

Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,038,525
  • Shares Outstanding, K 123,888
  • Annual Sales, $ 739,020 K
  • Annual Income, $ -436,370 K
  • EBIT $ -455 M
  • EBITDA $ -417 M
  • 60-Month Beta 1.49
  • Price/Sales 6.78
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 55.38% ( -1.01%)
  • Historical Volatility 63.45%
  • IV Percentile 10%
  • IV Rank 15.95%
  • IV High 103.43% on 04/04/25
  • IV Low 46.27% on 08/23/24
  • Put/Call Vol Ratio 1.02
  • Today's Volume 2,244
  • Volume Avg (30-Day) 2,545
  • Put/Call OI Ratio 1.05
  • Today's Open Interest 57,027
  • Open Int (30-Day) 48,207

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.77
  • Number of Estimates 5
  • High Estimate -0.67
  • Low Estimate -0.88
  • Prior Year -0.71
  • Growth Rate Est. (year over year) -8.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.86 +4.66%
on 05/07/25
52.92 -23.15%
on 05/01/25
-4.51 (-9.98%)
since 04/16/25
3-Month
34.88 +16.60%
on 03/10/25
52.92 -23.15%
on 05/01/25
-7.45 (-15.48%)
since 02/14/25
52-Week
20.14 +101.94%
on 10/25/24
52.92 -23.15%
on 05/01/25
+14.43 (+54.99%)
since 05/16/24

Most Recent Stories

More News
Guardant Health: A Promising Player in the Liquid Biopsy Market

NFLX : 1,191.53 (+1.15%)
GH : 40.67 (+0.52%)
NVDA : 135.40 (+0.42%)
Guardant Health’s (NASDAQ:GH) Q1: Strong Sales, Stock Soars

Guardant Health’s (NASDAQ:GH) Q1: Strong Sales, Stock Soars

GH : 40.67 (+0.52%)
Guardant Health: Q1 Earnings Snapshot

Guardant Health: Q1 Earnings Snapshot

GH : 40.67 (+0.52%)
Guardant Health (GH) Q1 Earnings Report Preview: What To Look For

Guardant Health (GH) Q1 Earnings Report Preview: What To Look For

GH : 40.67 (+0.52%)
DGX : 177.97 (+0.88%)
CNC : 61.78 (+2.86%)
Guardant Health (GH) Q1 Earnings Report Preview: What To Look For

Guardant Health (GH) Q1 Earnings Report Preview: What To Look For

GH : 40.67 (+0.52%)
DGX : 177.97 (+0.88%)
CNC : 61.78 (+2.86%)
RXO, The Ensign Group, LifeStance Health Group, Surgery Partners, and Guardant Health Stocks Trade Down, What You Need To Know

RXO, The Ensign Group, LifeStance Health Group, Surgery Partners, and Guardant Health Stocks Trade Down, What You Need To Know

GH : 40.67 (+0.52%)
RXO : 17.26 (+1.11%)
LFST : 5.84 (+0.86%)
ENSG : 149.75 (+1.84%)
SGRY : 23.94 (+1.29%)
3 Reasons to Sell GH and 1 Stock to Buy Instead

3 Reasons to Sell GH and 1 Stock to Buy Instead

YUM : 148.07 (+0.69%)
GH : 40.67 (+0.52%)
3 of Wall Street’s Favorite Stocks Facing Headwinds

3 of Wall Street’s Favorite Stocks Facing Headwinds

GH : 40.67 (+0.52%)
MATX : 114.97 (-1.00%)
HXL : 54.66 (+1.13%)
Reflecting On Testing & Diagnostics Services Stocks’ Q4 Earnings: Guardant Health (NASDAQ:GH)

Reflecting On Testing & Diagnostics Services Stocks’ Q4 Earnings: Guardant Health (NASDAQ:GH)

GH : 40.67 (+0.52%)
DGX : 177.97 (+0.88%)
NEO : 8.11 (+3.44%)
LH : 249.52 (+1.32%)
RDNT : 61.14 (+1.46%)
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)

GH : 40.67 (+0.52%)
DGX : 177.97 (+0.88%)
NEO : 8.11 (+3.44%)
LH : 249.52 (+1.32%)
RDNT : 61.14 (+1.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption,...

See More

Key Turning Points

3rd Resistance Point 42.04
2nd Resistance Point 41.55
1st Resistance Point 41.11
Last Price 40.67
1st Support Level 40.18
2nd Support Level 39.69
3rd Support Level 39.25

See More

52-Week High 52.92
Last Price 40.67
Fibonacci 61.8% 40.40
Fibonacci 50% 36.53
Fibonacci 38.2% 32.66
52-Week Low 20.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
OSZAR »